MEC Plus Events — 2025 MaTOS Breast 2025 MaTOS GU 2025 MCM 2025 PRIMO 2025 South Florida GI Cancer Symposium 2025 Winter Cancer Symposium (WCS) 2024 Advances in Oncology Conference 2024 Best of WCLC San Francisco 2024 California Cancer Consortium Conference (CCC) 2024 MaTOS Lungs 2024 MCM 2024 MLS Cleveland 2024 MLS Irvine 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PACC Miami 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 Updates in Cancer Therapies 2024 WCS Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Type of Media — Video Document Audio Author / Speaker Title Search Entries: « 1 … 31 32 33 34 35 … 100 » New Developments in EGFR and K-RAS Therapies in NSCLC Edgardo S. Santos, MD, FACP View PDF New Developments in Metastatic Breast Cancer: Immunotherapy and Novel Therapeutic Pathways Joyce O’Shaughnessy, MD View PDF Breast Cancer Update in Hormone Sensitive Breast Cancer Lauren Carcas, MD View PDF Novel Frontiers in the Use of ctDNA in Oncology Christian Rolfo, MD, PhD, MBA, Dr.hc. View PDF Developments in Head and Neck Cancers Including Thyroid Malignancies Moises Harari-Turquie, MD View PDF Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations Ritu Salani, MD, MBA View PDF Updates in Kidney and Bladder Cancers: Where we are with Immunotherapy and Precision Medicine? Karine Tawagi, MD View PDF Updates in Cholangiocarcinoma and Pancreas Cancer: What is new in Targeted Therapy or Immunotherapy? Milind M. Javle, MD View PDF Updates in Colorectal Cancer Fernando de Zarraga, MD View PDF Updates in Prostate Cancer: Combination Therapy Becoming the Best Approach? Chandler Park, MD, FACP View PDF Novel Therapies for Thymic Malignancies Jonathan Riess, MD View PDF Systemic Therapies for Mesothelioma Jorge E. Gomez, MD View PDF Radiation Induced Immune-Response in NSCLC Jeffrey Bradley, MD View PDF Optimal Surgical Approach for Mesothelioma Raja Flores, MD View PDF What Comes After Immunotherapy Failure in Terms of More Immunomodulation (Anti-Angiogenic Agents, IL-15, OX-40 and Others)? Ticiana Leal, MD View PDF Frontline: What are We Adding to Checkpoint Inhibitors and Chemotherapy? Jyoti Patel, MD View PDF Developing New Anti-CTL4s for NSCLC: Is There Any Role? Millie Das, MD View PDF The Role of Co-Mutations with Immunotherapy Response in NSCLC Ferdinando Skoulidis, MD View PDF Role of Radiotherapy in TIME: Good? Bad? Don’t know? Puneeth Iyengar, MD View PDF Overcoming T-Cell Exhaustion Brian S. Henick, MD View PDF The New Role of Microbiome in Lung Cancer Immunotherapy David Carbone, MD View PDF Role of Interleukins in TIME to Improve Immunotherapy Efficacy Suresh Ramalingam, MD View PDF The Importance of TIME in Cancer Fight: How to Target It? Hossein Borghaei, DO View PDF CAR-T Cell in NSCLC: Is it Feasible? Sally Lau, MD View PDF Updates in Bispecific Antibodies in NSCLC Lyudmila Bazhenova, MD View PDF Targeting CEACAM5 and ROR1/ROR2 in NSCLC Paul Bunn, MD View PDF TROP-2 and AXL as Targets in NSCLC Stephen Liu, MD View PDF Building the Case for HER-2 Inhibitors in NSCLC Corey Langer, MD View PDF HER-3 as a New Target in NSCLC Edgardo S. Santos, MD View PDF Brain Radiotherapy in SCLC: When? Jeffrey Bradley, MD View PDF
